A Systematic Review of Economic Aspects of Service Interventions to Increase Anticoagulation Use in Atrial Fibrillation

Author:

Jones Nicholas R.1,Crawford William2,Yang Yaling1,Hobbs F.D. Richard1,Taylor Clare J.1,Petrou Stavros1

Affiliation:

1. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

2. Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom

Abstract

Abstract Objective To systematically identify and appraise existing evidence surrounding economic aspects of anticoagulation service interventions for patients with atrial fibrillation. Methods We searched the published and grey literature up to October 2019 to identify relevant economic evidence in any health care setting. A narrative-synthesis approach was taken to summarise evidence by economic design and type of service intervention, with costs expressed in pound sterling and valued at 2017 to 2018 prices. Results A total of 13 studies met our inclusion criteria from 1,168 papers originally identified. Categories of interventions included anticoagulation clinics (n = 4), complex interventions (n = 4), decision support tools (n = 3) and patient-centred approaches (n = 2). Anticoagulation clinics were cost-saving compared with usual care (range for mean cost difference: £188–£691 per-patient per-year) with equivalent health outcomes. Only one economic evaluation of a complex intervention was conducted; case management was more expensive than usual care (mean cost difference: £255 per-patient per-year) and the probability of its cost-effectiveness did not exceed 70%. There was limited economic evidence surrounding decision support tools or patient-centred approaches. Targeting service interventions at high-risk groups and those with suboptimal treatment was most likely to result in cost savings. Conclusion This review revealed some evidence to support the cost-effectiveness of anticoagulation clinics. However, summative conclusions are constrained by a paucity of economic evidence, a lack of direct comparisons between interventions, and study heterogeneity in terms of intervention, comparator and study year. Further research is urgently needed to inform commissioning and service development. Data from this review can inform future economic evaluations of anticoagulation service interventions.

Funder

Wellcome Trust Doctoral Research Fellowship

Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Oxford

National Institute for Health Research (NIHR) School for Primary Care Research

NIHR Collaboration for Leadership in Health Research and Care (CLARHC) Oxford

NIHR Oxford Biomedical Research Centre

NIHR Oxford Medtech

In-Vitro Diagnostics Co-operative

NIHR Academic Clinical Lectureship

NIHR

Publisher

Georg Thieme Verlag KG

Subject

Hematology

Reference34 articles.

1. Atrial fibrillation: the current epidemic;C A Morillo;J Geriatr Cardiol,2017

2. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060;B P Krijthe;Eur Heart J,2013

3. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;R G Hart;Ann Intern Med,2007

4. Influence of direct oral anticoagulants on rates of oral anticoagulation for atrial fibrillation;L N Marzec;J Am Coll Cardiol,2017

5. Anticoagulant prescribing for non-valvular atrial fibrillation in the veterans health administration;A J Rose;J Am Heart Assoc,2019

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3